MyAverix Finance
SHG · Healthcare
Chengdu Olymvax Biopharmaceuticals Inc. A (688319)
Biotechnology
Chengdu Olymvax Biopharmaceuticals Inc. A (688319) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $12.07B, P/E ratio is 185.88, net margin is 3.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688319
Chengdu Olymvax Biopharmaceuticals Inc. A (688319) — FAQ
What is Chengdu Olymvax Biopharmaceuticals Inc. A's market cap?
Chengdu Olymvax Biopharmaceuticals Inc. A (688319) has a reported market cap of $12.07B (data as of 2026-03-29).
What is 688319's P/E ratio?
The price-to-earnings (P/E) ratio for Chengdu Olymvax Biopharmaceuticals Inc. A (688319) is 185.88 (data as of 2026-03-29).
Does Chengdu Olymvax Biopharmaceuticals Inc. A pay a dividend?
Dividend yield is not available in the current snapshot for Chengdu Olymvax Biopharmaceuticals Inc. A (688319). Check the MyAverix Finance app for the latest dividend data.
What sector is Chengdu Olymvax Biopharmaceuticals Inc. A in?
Chengdu Olymvax Biopharmaceuticals Inc. A (688319) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688319 listed on?
688319 is listed on SHG.
What is Chengdu Olymvax Biopharmaceuticals Inc. A's net margin?
Chengdu Olymvax Biopharmaceuticals Inc. A (688319) reports a net margin of 3.2% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.